| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |
| 06/08/2002 | CA2364760A1 Anti-abnormal type prion monoclonal antibody, process for producing the same, and immunoassay using the same |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044345A1 Methods and products for manipulating hematopoietic stem cells |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044217A2 Humanised antibodies and uses thereof |
| 06/06/2002 | WO2002044216A1 Probes for identifying cancer-specific antigens |
| 06/06/2002 | WO2002044215A2 Hybrid antibodies |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044206A2 Membrane fusion proteins derived from reovirus |
| 06/06/2002 | WO2002043747A2 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | WO2002043570A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
| 06/06/2002 | WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies |
| 06/06/2002 | WO2002024223A3 Prevention and treatment of streptococcal and staphylococcal infection |
| 06/06/2002 | WO2002020555A3 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 06/06/2002 | WO2002016440A3 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 06/06/2002 | WO2002010764A3 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 06/06/2002 | WO2001098359A3 Cyr61 as a target for treatment and diagnosis of breast cancer |
| 06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001075453A3 Methods involving induced dimerisation by cellular components |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001002012A8 Remedies for drug-resistant hypercalcemia |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | WO2000022430A3 Neisseria genomic sequences and methods of their use |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068823 33877 and 47179, novel human glycosyltransferase family members and uses thereof |
| 06/06/2002 | US20020068813 Sulfated CCR5 peptides for HIV-1 infection |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068368 Viruses to be removed being increased in size by binding to ligands and being held back by filtration. |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
| 06/06/2002 | US20020068345 98P7C3: homeodomain protein highly expressed in various cancers |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068276 Methods for selecting functional polypeptides |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068066 Method for the treatment and prevention of dental caries |
| 06/06/2002 | US20020068064 Monoclonal antibodies for the detection of decoy receptor 3, hybridomas producing said antibodies and uses thereof |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068060 Contacting the interleukin-18 (IL-18) receptor with an antibody which binds to said receptor to antagonize signalling mediated by IL-18; treating autoimmune or inflammatory conditions |
| 06/06/2002 | US20020068059 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 06/06/2002 | US20020068058 Autoantibody inhibitors |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10131426A1 Heat pasteurization of immunoglobulin Y, e.g. for pharmaceutical use, using specific temperature and time conditions allowing inactivation of viruses while retaining antibody activity |
| 06/06/2002 | DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | DE10055285A1 Neue Marker für die Diagnose und Therapie von Tumoren New marker for the diagnosis and therapy of tumors |
| 06/06/2002 | CA2604066A1 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430745A1 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430528A1 Hybrid antibodies |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430473A1 Diagnosis and treatment of disease |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430084A1 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
| 06/06/2002 | CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1210606A1 Cartilage resorption assays |
| 06/05/2002 | EP1210604A1 Methods and kits for diagnosing or monitoring a synovial or osteoarticular pathology comprising the use of a specific marker of the synovial tissue degradation |
| 06/05/2002 | EP1210603A2 Anti-epha2 antibodies as a cancer diagnostic |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |